Lophos Pharmaceuticals Corp. Commences Peyote Research Protocol
02 mai 2024 08h00 HE
|
Lophos Holdings Inc.
NAPANEE, Ontario, May 02, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is pleased to announce the official commencement of its first research protocol under...
Lophos Pharmaceuticals Corp. Expands Peyote Cultivation with the Successful Planting of 3,000 Seeds
25 avr. 2024 08h00 HE
|
Lophos Holdings Inc.
VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. (CSE: MESC) ("Lophos" or the "Company") proudly announces a milestone accomplishment from its subsidiary, Lophos...
Lophos Pharmaceuticals’ Licensed Site Celebrates Successful Building Occupancy
17 avr. 2024 08h00 HE
|
Lophos Holdings Inc.
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. (“Lophos” or the “Company”) (CSE:MESC) is delighted to announce the successful receipt of building occupancy for...
ThreeD Capital Inc. and Lophos Holdings Inc. Announce Strategic Partnership
15 avr. 2024 08h00 HE
|
Lophos Holdings Inc.
VANCOUVER, British Columbia, April 15, 2024 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. ("ThreeD"), a publicly traded Canadian-based venture capital firm focused on opportunistic investments in...
Lophos Holdings Inc. Celebrates Successful Conclusion of Inaugural Annual General Meeting, Confirms Board Members and Stock Options Plan
28 mars 2024 18h43 HE
|
Lophos Holdings Inc.
VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. (CSE: MESC) ("Lophos" or the "Company") is pleased to announce all matters presented for approval at the annual...
Lophos Pharmaceuticals Partners With Carmichael Engineering Ltd. for HVAC Project, Anticipates Expedited Building Occupancy
05 mars 2024 07h55 HE
|
Lophos Holdings Inc.
NAPANEE, Ontario, March 05, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos" or the "Company") (CSE:MESC) is pleased to announce its subsidiary, Lophos Pharmaceuticals Corp., has selected...
Lophos Confirms Appearance at Benzinga Capital Conference in Hollywood, Florida and Finalizes Annual General Meeting
28 févr. 2024 08h00 HE
|
Lophos Holdings Inc.
NAPANEE, Ontario, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is thrilled to announce its wholly-owned subsidiary, Lophos Pharmaceuticals Corp.,...
Lophos Pharmaceuticals Corp. Finalizes the Development of a New Research Protocol for Lophophora Williamsii (Peyote)
14 févr. 2024 09h04 HE
|
Lophos Holdings Inc.
NAPANEE, Ontario, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is thrilled to provide further insights into the accomplishments of its wholly-owned...
Lophos Pharmaceuticals Corp. Finalizes the Development of a New Synthetic Mescaline Protocol
08 févr. 2024 08h00 HE
|
Lophos Holdings Inc.
NAPANEE, Ontario, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is thrilled to provide further insights into the accomplishments of its wholly-owned...
Lophos Pharmaceuticals Corp. Finalizes Product Release Specifications for Fresh and Dried Peyote (Lophophora williamsii)
31 janv. 2024 08h00 HE
|
Lophos Holdings Inc.
NAPANEE, Ontario, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is thrilled to provide further insights into the accomplishments of its wholly-owned...